| |
HLA-DRB1 Shared epitope
QKRAA/QRRAA/RRRAA
Reverse hybridization kit for the detection
of the shared epitope QKRAA/QRRAA/RRRAA of rheumatoid arthritis in
all known HLA-DRB1 alleles; differentiation between homozygot and
heterozygot
RDB2035
>> Principles
of the test
>> Examples
for the detection
Nomenclature and clinical relevance,
References
|
|
Nomenclature of the HLA-DR
Alleles
The MHC class ll are cell surface molecules which perform an
essential function in immunological detection using T-helper cells.
They are encoded by the genes HLA-DR, -DQ and -DP. Each MHC molecule
consists of a a- and a b-chain. In the case of the DR molecule, the
two chains are encoded by the genes HLA-DRA und HLA-DRB1; only DRB1
is polymorph i.e. only this gene has a number of different alleles
existing in the population. In addition, each individual possesses
two DRB1 alleles, one from each parent.
The serological typification of the DR alleles leads to the differentiation
between 10 different classes, HLA-DR1-DR10. Molecular genetic typification
shows that these classes can be further split e.g. DR2 has deen divided
into DR15 and DR16. Within these classes it is possible to distinguish
between a number of subtypes. Up until now, 33 subtypes of DR4 have
been described, and are termed HLA-DRB1*0401-*0433.
|
 |
Clinicale relevance of
the shared epitope
Rheumatoid arthritis (RA) or chronic polyarthritis is an intermittent
systemic autoimmune disease which occurs in approx. 1% of the population.
The aetiology of the disease is unknown.
It has been shown for some time by numerous studies that there is
a genetic disposition for RA caused by several alleles of the HLA-DRB1
region. RA is associated with the HLA- DRB1*04 subtypes DRB1*0401,
*0404, *0405, *0408 and also, in some different ethnic groups with
the subtypes DRB1*0101, *0102 and DRB1*1001.
All RA-associated HLA-DRB1 alleles encode in their third hypervariable
region, at postion 70-74, the amino acids QKRAA (*0401), QRRAA (*0404,
*0405, *0408, *0101, *0102) or RRRAA (*1001). This so-called rheumatoid
epitope or shared epitope can be found in approximately 80-90% of
all Caucasian RA patients.
It is not known how the shared epitope in HLA-DRB1*04 supports the
development of RA.
Tests show that, alongside the higher risk of RA, the shared epitope
can also be a prognostic marker for the clinical course and severity
of the disease. In addition to this, numerous studies have shown a
gene-dose effect. Patients homozygous for the shared epitope have
more often a more severe course of disease than those with only one
shared epitope allele (see chart).
|
 |
HLA-DRB1 Alleles:
Allele 1 |
Allele 2 |
RA: Severity of
joints involvement |
RA: Vasculitis |
| DRB1*04-QKRAA |
DRB1*04-QKRAA |
+++ |
+++ |
| DRB1*04-QKRAA |
DRB1*04-QRRAA |
++ |
+ |
| DRB1*04-QRRAA |
DRB1*04-QRRAA |
++ |
+ |
| DRB1*04-QKRAA |
DRB1*01-QRRAA |
++ |
- |
| DRB1*04-QRRAA |
DRB1*01-QRRAA |
++ |
- |
| DRB1*04-QKRAA |
no shared epitope |
+ |
+ |
| DRB1*04-QRRAA |
no shared epitope |
+ |
- |
| DRB1*01-QRRAA |
DRB1*01-QRRAA |
+ |
- |
| DRB1*01-QRRAA |
no shared epitope |
+ |
- |
| no shared epitope |
no shared epitope |
- |
- |
|
 |
Chart changed from Internist 40: 922-929 (1999)
Infection with the spirochete Borrelia burgdorferi causes
Lyme disease. Roughly 10% of the patients develop a antibiotic treatment-resistant
Lyme arthritis.
People with the shared epitope QKRAA allels of the HLA-DRB1*04 group
are also genetically predisposed to this kind of arthritis.
Typing of the shared epitope in the HLA-DRB1 alleles seems necessary
to
- predict the clinical course of the disease
in Patients with the diagnosis rheumatoid arthritis
- identify patients of risk, for a more
agressiv therapy in an early stage of the disease
- identify patients with antibiotic
treatment-resistant Lyme arthritis
|
 |
References
Weyand CM et al. (1995)
Inherited and noninherited risk factors in rheumatoid arthritis
Curr Opin in Rheumatol 7: 206-213
Nepom GT et al. (1996)
Prognostic implications of HLA genotyping in the early assessment
of patients with rheumatoid arthritis
J Rheumatol Suppl 44: 5-9
Wagner U et al. (1997)
HLA markers and prediction of clinical course and outcome in rheumatoid
arthritis
Arthritis and Rheumatism 40: 341-351
Perdriger A et al. (1997)
Role of HLA-DR-DR and DR-DQ Associations in the Expression of Extraarticular
Manifestations and Rheumatoid Factor in Rheumatoid Arthritis
J Rheumatol 24: 1272-1276
Stavropoulos C et al. (1997)
HLA-DRB1 allels in Greek rheumatoid arthritis patients and their association
with clinical characteristics
Eur J Immunogenet 24: 265-274
Rowley MJ et al. (1997)
The Effect of HLA-DRB1 Disease Susceptibility Markers on the Expression
of RA
Scand J Rheumatol 26: 448-455
O�Dell JR et al. (1998)
HLA-DRB1 typing in rheumatoid arthritis: predicting response to specific
treatments
Ann Rheum Dis 57: 209-213
Reveille JD (1998)
The genetic contribution to the pathogenesis of rheumatoid arthritis
Curr Opin Rheumatol 10: 187-200
Istanbul rheumatology study group (1998)
Shared epitope �homozygosity� is strongly associated with rheumatoid
arthritis in Turkey
British J of Rheumatology 37: 1126-1128
Toussirot E et al. (1999)
HLA-DRB1 Alleles and Shared Amino Acid Sequences in Disease Susceptibility
and Severity in Patients from Eastern France with Rheumatoid Arthritis
J of Rheumatol 26: 1446-1451
Valenzuela A et al. (1999)
Association of HLA shared epitope with joint damage progression in
rheumatoid arthritis
Hum Immunol 60: 250-254
Meyer MJ et al. (1999)
HLA-DRB1 Genotype Influences Risk for and Severity of Rheumatoid Arthritis
J Rheumatol 26: 1024-1034
Nitzsche et al. (1999)
Entz�ndungsmechanismen bei rheumatoider Vaskulitis und Riesenzellarteriitis
Internist 40: 922-929
>> Principles
of the test
>> Examples
for the detection |
 |
|
|